openPR Logo
Press release

US Cardiac Biomarker Market: Market Size, Industry Trends, Leading Players, Market and Forecast 2019- Share 2025

01-14-2020 06:36 AM CET | Science & Education

Press release from: Orion Market Reports

US Cardiac Biomarker Market

US Cardiac Biomarker Market

The US Cardiac Biomarker Market is estimated to grow significantly at a CAGR of 7.2% during the forecast period. The major factors that propel the market growth include the high prevalence of CVDs and heart-related diseases in the country coupled with robust healthcare expenditure.

According to the CDC about half of the people who develop heart failure die within 5 years of diagnosis. Heart failure costs the nation an estimated $30.7 billion each year. This total includes the cost of healthcare services, medications to treat heart failure, and missed days of work. High healthcare expenditure in the US enabling the growth of the market.

To learn more about this report request a free sample copy @ https://www.omr.com/request-sample/us-cardiac-biomarker-market

According to the Centre for Disease Control & Prevention (CDC), the US national healthcare expenditure was around $3.3 trillion in 2016. The US has the highest healthcare spending across the globe. In the US per capita, healthcare expenditure is around $10,348 per person, in 2016. The high healthcare expenditure raises the demand for advanced diagnostic technologies such as cardiac biomarkers that further peoples the market growth in the country.

The market is segmented on the basis of type, application, and location of testing. Based on type, the market is segregated into Creatine kinase (CK-MB), Troponins (T, I), Myoglobin, Natriuretic peptides (BNP & NT-PROBNP), Ischemia modified albumin and Others.

The troponin is anticipated to be the fastest growing and has a considerable market share in the US cardiac biomarker market due to easy and high sensitivity that results in the high adoption of the test. Based on Application, the market is segmented into myocardial infraction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. On the basis of the location of testing, the market is classified into laboratory testing and point of care testing.

A full report of US Cardiac Biomarker Market is available at https://www.omr.com/industry-reports/us-cardiac-biomarker-market

US Cardiac Biomarker Market-Segmentation

By Type
• Creatine kinase (CK-MB)
• Troponins(T,I)
• Myoglobin
• Natriuretic peptides (BNP & NT-PROBNP)
• Ischemia modified albumin
• Others
By Application
• Myocardial infraction
• Congestive heart failure
• Acute coronary syndrome
• Atherosclerosis
• Others
By Location of Testing
• Laboratory testing
• Point of care testing

Company Profiles
• Abbott Laboratories
• Becton, Dickinson, and Co.
• Bio-Rad Laboratories, Inc.
• Creative Diagnosis
• Critical Diagnostics
• Danaher Corp.
• LifeSign LLC
• Meso Scale Diagnostics LLC
• Myriad RBM
• Thermo Fisher Scientific Inc.

For more customized data, request for report customization @ https://www.omr.com/report-customization/us-cardiac-biomarker-market

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +1 646-755-7667, +91 780-304-0404

Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Cardiac Biomarker Market: Market Size, Industry Trends, Leading Players, Market and Forecast 2019- Share 2025 here

News-ID: 1895234 • Views: 119

More Releases from Orion Market Reports

Global Emotion Analytics Market: Market Size, Share and Forecast 2019-2025
The Global Emotion Analytics is anticipated to show lucrative growth at the CAGR of 12.4% during 2019-2025. The rapid adoption of cloud computing services across several enterprises is a major factor to drive the growth of the global emotion analytics market. The growing significance of big data and advanced analytics is further supporting the increase in the utility of cloud computing for understanding the behavior of the customers through the
Content Intelligence Market Segmentation, Forecast, Market Analysis, Global Indu …
Content Intelligence Market is anticipated to grow at a CAGR of 28.2% during the forecast period. The rising adoption of new advanced techniques such as machine learning (ML), artificial intelligence (AI), big data and Natural Language Processing (NLP) is fueling the growth of the content intelligence market. Machine learning is the subset of AI and is impacting almost every industry such as automobile, advertising, retail, and finances apart from that
Global Air Duct Market: Global Industry Trends, Market Size, Competitive Analysi …
The Global Air Duct Market is expected to grow at a CAGR of 4.2% owing to the rising application in the end-user industry such as office space, airport & rapid transit, retail stores and shopping complex, hospitality and manufacturing. Heating, Ventilation, and air conditioning (HVAC) system are used for cooling and heating buildings such as residential, commercial and industrial. Duct heaters are utilized for heating commercial and industrial buildings. The
Abdominal Aortic Aneurysm Repair Devices Market: Global Industry Growth, Market …
The Abdominal Aortic Aneurysm Repair Devices Market is anticipated to grow at a CAGR of 7.2% during the forecast period. The increasing utilization of endovascular repair treatment is a major factor to boost the growth of the abdominal aortic aneurysm repair devices market. It offers a safer treatment option for patients with advanced age, cardiac condition, and renal dysfunction. The successful endovascular repair of AAA depends on the factors that

All 5 Releases


More Releases for Cardiac

Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,
Ambulatory Cardiac Monitoring Devices
Ambulatory Cardiac Monitoring Devices Market by Product (Ambulatory Rhythm Monitor, Ambulatory ECG Monitor, Ambulatory Cardiac Event Monitor, Implantable Loop Recorder, Ambulatory real-time Cardiac Monitors, Cardiac Output Monitors); by End-User (Hospitals, Ambulatory Care Centers); by Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) –
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Stupendous Growth …
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are
Mexico Cardiac Assist Devices
Mexico Cardiac Assist Devices Overview "Mexico Cardiac Assist Devices Market Outlook to 2025", provides key market data on the Mexico Cardiac Assist Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices. Click here for sample report @ https://www.wiseguyreports.com/sample-request/3107735-mexico-cardiac-assist-devices-market-outlook-to-2025   Major Key Players: Abbott Laboratories Medtronic plc Getinge AB. Major Highlight of the report: The report also provides
Cardiac Monitoring & Cardiac Rhythm Management Market Review and Forecast 2025
Crystalmarketresearch.com published “Cardiac Monitoring & Cardiac Rhythm Management Market By Component, Technology, Application, And End User - Global Industry Analysis And Forecast To 2025” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. The cardiac monitoring & cardiac rhythm management market is expected to be worth $XX billion by 2025. The market is largely driven by factors such as rising incidence of cardiovascular
Cardiac Monitoring & Cardiac Rhythm Management Devices Market
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are